(19)
(11) EP 4 422 657 A1

(12)

(43) Date of publication:
04.09.2024 Bulletin 2024/36

(21) Application number: 21802667.2

(22) Date of filing: 29.10.2021
(51) International Patent Classification (IPC): 
A61K 38/00(2006.01)
A61P 35/00(2006.01)
C07K 16/40(2006.01)
 A61K 39/395(2006.01)
C07K 16/28(2006.01)
G01N 33/574(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/40; C07K 2317/569; C07K 16/2803; A61K 2039/505; A61P 35/00; A61K 39/395; A61K 45/06; A61K 33/243
 
C-Sets:
  1. A61K 39/395, A61K 2300/00;
  2. A61K 33/243, A61K 2300/00;
(86) International application number:
PCT/EP2021/080177
(87) International publication number:
WO 2023/072405 (04.05.2023 Gazette 2023/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(71) Applicants:
  • BIO-Y A/S
    3000 Helsingør (DK)
  • Universitätsklinikum Hamburg-Eppendorf
    20246 Hamburg (DE)

(72) Inventors:
  • KRISTENSEN, Peter
    8310 Tranbjerg (DK)
  • MINOR, Peter
    2100 Copenhagen Ø (DK)
  • SCHUMACHER, Udo
    20246 Hamburg (DE)
  • BÖCKELMANN, Lukas Clemens
    22769 Hamburg (DE)

(74) Representative: Høiberg P/S 
Adelgade 12
1304 Copenhagen K
1304 Copenhagen K (DK)

   


(54) YKL-40 ANTIBODY AND USES THEREOF